2009
DOI: 10.1051/medsci/2009255473
|View full text |Cite
|
Sign up to set email alerts
|

Glycannes pariétaux de levures et anticorps spécifiques

Abstract: Une des spécificités « historiques » de la mycologie médi-cale est d'utiliser les anticorps expérimentaux et humains produits contre les molécules fongiques afin de mieux comprendre la biologie des champignons et les processus pathologiques qu'ils induisent, et d'en faciliter le diagnostic [4][5][6]. Chez les champignons, les « glycannes » 1 représentent jusqu'à 80 % de la paroi [1-3] et il n'est donc pas étonnant que pour les espèces impliquées en pathologie humaine, ils soient la cible privilégiée de la répo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 50 publications
0
3
0
1
Order By: Relevance
“…The increasing incidence of Crohn's disease and other inflammatory bowel diseases, which previously were only prevalent in populations with a strong genetic component, is also an important factor [77][78][79][80][81][82][83][84][85][86].…”
Section: Drugs and Prolonged Use Of Antibioticsmentioning
confidence: 99%
“…The increasing incidence of Crohn's disease and other inflammatory bowel diseases, which previously were only prevalent in populations with a strong genetic component, is also an important factor [77][78][79][80][81][82][83][84][85][86].…”
Section: Drugs and Prolonged Use Of Antibioticsmentioning
confidence: 99%
“…in chronic mucocutaneous candidiasis (CMC) patients) 8 . Perturbations in the composition of the competitive commensal bacteria can also predispose individuals to C. albicans infections, and distorted immunological responses against C. albicans have been proposed to contribute to the pathological autoinflammation that occurs in patients with Crohn’s disease 9 .…”
mentioning
confidence: 99%
“…In addition, SCFAs can be used as hosts to reduce oxygen concentration and create an environment that is not conducive to fungal growth (Rivera-Chavez et al, 2016). Probiotics can also inhibit pathogen adhesion to intestinal epithelium by producing bacteriocins and SCFAs; improve the barrier function of intestinal mucosa by increasing mucus layer and producing tight junction proteins; stimulate the production of secretory IgA to improve intestinal immunity, and then relieve metabolic diseases and intestinal disorders diseases such as IBD, IBS and colorectal cancers (Sendid et al, 2009;Eslami et al, 2019;Simon et al, 2021).…”
Section: Probiotics Produce Active Metabolites To Inhibit Fungimentioning
confidence: 99%